{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:31:56Z","timestamp":1780554716634,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Chongqing Health and Family Planning Commission Fund","award":["2016MSXM033"],"award-info":[{"award-number":["2016MSXM033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12519-019-00316-5","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T12:06:56Z","timestamp":1571054816000},"page":"68-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Infliximab therapy and outcomes in patients with polyarticular juvenile idiopathic arthritis: a single-center study in China"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6995-3606","authenticated-orcid":false,"given":"Da-Wei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao-Jiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Mei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,14]]},"reference":[{"key":"316_CR1","first-page":"390","volume":"31","author":"R Petty","year":"2004","unstructured":"Petty R, Southwood T, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classifications of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"316_CR2","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369:767\u201378.","journal-title":"Lancet"},{"key":"316_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jbspin.2013.09.003","volume":"81","author":"S Thierry","year":"2014","unstructured":"Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 2014;81:112\u20137.","journal-title":"Jt Bone Spine"},{"key":"316_CR4","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.autrev.2015.04.007","volume":"14","author":"E Rochette","year":"2015","unstructured":"Rochette E, Duche P, Merlin E. Juvenile idiopathic arthritis and physical activity: possible inflammatory and immune modulation and tracks for interventions in young populations. Autoimmun Rev. 2015;14:726\u201334.","journal-title":"Autoimmun Rev"},{"key":"316_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4274\/balkanmedj.2017.0111","volume":"34","author":"K Barut","year":"2017","unstructured":"Barut K, Adrovic A, \u015eahin S, Kasap\u00e7opur \u00d6. Juvenile idiopathic arthritis. Balkan Med J. 2017;34:90\u2013101.","journal-title":"Balkan Med J"},{"key":"316_CR6","first-page":"2290","volume":"31","author":"CA Wallace","year":"2004","unstructured":"Wallace CA, Ruperto N, Giannini E, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology International Trials Organization, Pediatric Rheumatology Collaborative Study Group. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31:2290\u20134.","journal-title":"J Rheumatol"},{"key":"316_CR7","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/art.23916","volume":"59","author":"S Magni-Manzoni","year":"2008","unstructured":"Magni-Manzoni S, Ruperto N, Pistorio A, Sala E, Solari N, Palmisani E, et al. Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2008;59:1120\u20137.","journal-title":"Arthritis Rheum"},{"key":"316_CR8","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/BOR.0000000000000632","volume":"31","author":"G Giancane","year":"2019","unstructured":"Giancane G, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO). Treatment of juvenile idiopathic arthritis: what's new? Curr Opin Rheumatol. 2019;31:428\u201335.","journal-title":"Curr Opin Rheumatol"},{"issue":"71","key":"316_CR9","first-page":"194","volume":"2013","author":"PJ Kahn","year":"2013","unstructured":"Kahn PJ. Juvenile idiopathic arthritis - what the clinician needs to know. Bull Hosp Jt Dis (2013). 2013;71:194\u20139.","journal-title":"Bull Hosp Jt Dis (2013)"},{"key":"316_CR10","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1136\/annrheumdis-2014-205372","volume":"74","author":"J Guzman","year":"2015","unstructured":"Guzman J, Oen K, Tucker LB, Huber AM, Shiff N, Boire G, et al. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort. Ann Rheum Dis. 2015;74:1854\u201360.","journal-title":"Ann Rheum Dis"},{"key":"316_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2147\/CEOR.S197117","volume":"11","author":"A Marshall","year":"2019","unstructured":"Marshall A, Gupta K, Pazirandeh M, Bonafede M, McMorrow D. Treatment patterns and economic outcomes in patients with juvenile idiopathic arthritis. Clinicoecon Outcomes Res. 2019;11:361\u201371.","journal-title":"Clinicoecon Outcomes Res"},{"key":"316_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fphar.2011.00060","volume":"2","author":"N Ruperto","year":"2011","unstructured":"Ruperto N, Martini A. Current medical treatments for juvenile idiopathic arthritis. Front Pharmacol. 2011;2:60.","journal-title":"Front Pharmacol"},{"key":"316_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1546-0096-12-13","volume":"12","author":"ML Stoll","year":"2014","unstructured":"Stoll ML, Cron RQ. Treatment of juvenile idiopathic arthritis: a revolution in care. Pediatr Rheumatol Online J. 2014;12:13.","journal-title":"Pediatr Rheumatol Online J"},{"key":"316_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.semarthrit.2012.10.006","volume":"42","author":"WJ Ungar","year":"2013","unstructured":"Ungar WJ, Costa V, Burnett HF, Feldman BM, Laxer RM. The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis: a systematic review. Semin Arthritis Rheum. 2013;42:597\u2013618.","journal-title":"Semin Arthritis Rheum"},{"key":"316_CR15","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00296-018-4062-9","volume":"38","author":"P Nalbanti","year":"2018","unstructured":"Nalbanti P, Kanakoudi-Tsakalidou F, Trachana M, Pratsidou-Gertsi P, Farmaki E, Bamidis P, et al. Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment. Rheumatol Int. 2018;38:1241\u201350.","journal-title":"Rheumatol Int"},{"key":"316_CR16","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/acr.22903","volume":"68","author":"NJ Luca","year":"2016","unstructured":"Luca NJ, Burnett HF, Ungar WJ, Moretti ME, Beukelman T, Feldman BM, et al. Cost-effectiveness analysis of first-line treatment with biologic agents in polyarticular juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2016;68:1803\u201311.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"316_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1517\/14712598.2013.735657","volume":"13","author":"G Horneff","year":"2013","unstructured":"Horneff G. Update on biologicals for treatment of juvenile idiopathic arthritis. Expert Opin Biol Ther. 2013;13:361\u201376.","journal-title":"Expert Opin Biol Ther"},{"key":"316_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12969-019-0305-x","volume":"17","author":"A Nagy","year":"2019","unstructured":"Nagy A, M\u00e1trai P, Hegyi P, Alizadeh H, Bajor J, Czopf L, et al. The effects of TNF-alpha inhibitor therapy on the incidence of infection in JIA children: a meta-analysis. Pediatr Rheumatol Online J. 2019;17:4.","journal-title":"Pediatr Rheumatol Online J"},{"key":"316_CR19","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/art.24516","volume":"61","author":"A Consolaro","year":"2009","unstructured":"Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum. 2009;61:658\u201366.","journal-title":"Arthritis Rheum"},{"key":"316_CR20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/art.27218","volume":"62","author":"PJ Hashkes","year":"2010","unstructured":"Hashkes PJ, Wright BM, Lauer MS, Worley SE, Tang AS, Roettcher PA, et al. Mortality outcomes in pediatric rheumatology in the US. Arthritis Rheum. 2010;62:599\u2013608.","journal-title":"Arthritis Rheum"},{"key":"316_CR21","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1002\/art.21389","volume":"52","author":"CA Wallace","year":"2005","unstructured":"Wallace CA, Huang B, Bandeira M, Ravelli A, Giannini EH. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum. 2005;52:3554\u2013622.","journal-title":"Arthritis Rheum"},{"key":"316_CR22","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/rheumatology\/kep144","volume":"48","author":"S Ringold","year":"2009","unstructured":"Ringold S, Seidel KD, Koepsell TD, Wallace CA. Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations. Rheumatology (Oxford). 2009;48:972\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"316_CR23","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/acr.22259","volume":"66","author":"S Ringold","year":"2014","unstructured":"Ringold S, Weiss PF, Colbert RA, DeWitt EM, Lee T, Onel K, et al. Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2014;66:1063\u201372.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"316_CR24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2165\/11532610-000000000-00000","volume":"12","author":"S Shenoi","year":"2010","unstructured":"Shenoi S, Wallace CA. Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review. Paediatr Drugs. 2010;12:367\u201377.","journal-title":"Paediatr Drugs"},{"key":"316_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2474-9-52","volume":"9","author":"A Alonso-Ruiz","year":"2008","unstructured":"Alonso-Ruiz A, Pijoan JI, Ansuategui E, Urkaregi A, Calabozo M, Quintana A. Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety. BMC Musculoskelet Disord. 2008;9:52.","journal-title":"BMC Musculoskelet Disord"},{"key":"316_CR26","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00431-017-2960-6","volume":"176","author":"F Vanoni","year":"2017","unstructured":"Vanoni F, Minoia F, Malattia C. Biologics in juvenile idiopathic arthritis: a narrative review. Eur J Pediatr. 2017;176:1147\u201353.","journal-title":"Eur J Pediatr"},{"key":"316_CR27","first-page":"281","volume":"29","author":"V Marzetti","year":"2017","unstructured":"Marzetti V, Breda L, Miulli E, Filippetti F, Mancini C, Chiarelli F, et al. Clinical characteristics of juvenile idiopathic arthritis in an area of central Italy: a population-based study. Ann Ig. 2017;29:281\u201392.","journal-title":"Ann Ig"},{"key":"316_CR28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/ICU.0b013e32833eab83","volume":"21","author":"Y Qian","year":"2010","unstructured":"Qian Y, Acharya NR. Juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol. 2010;21:468\u201372.","journal-title":"Curr Opin Ophthalmol"},{"key":"316_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12969-016-0088-2","volume":"14","author":"SL Clarke","year":"2016","unstructured":"Clarke SL, Sen ES, Ramanan AV. Juvenile idiopathic arthritis-associated uveitis. Pediatr Rheumatol Online J. 2016;14:27.","journal-title":"Pediatr Rheumatol Online J"},{"key":"316_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2019.06.001","author":"JL Hayworth","year":"2019","unstructured":"Hayworth JL, Turk MA, Nevskaya T, Pope JE. The frequency of uveitis in patients with juvenile inflammatory rheumatic diseases. Joint Bone Spine. 2019. https:\/\/doi.org\/10.1016\/j.jbspin.2019.06.001 .","journal-title":"Joint Bone Spine"},{"key":"316_CR31","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2012-202031","volume":"72","author":"F McErlane","year":"2013","unstructured":"McErlane F, Beresford MW, Baildam EM, Chieng SE, Davidson JE, Foster HE, et al. Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis. Ann Rheum Dis. 2013;72:1983\u20138.","journal-title":"Ann Rheum Dis"},{"key":"316_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12969-016-0085-5","volume":"14","author":"A Consolaro","year":"2016","unstructured":"Consolaro A, Giancane G, Schiappapietra B, Dav\u00ec S, Calandra S, Lanni S, et al. Clinical outcome measures in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2016;14:23.","journal-title":"Pediatr Rheumatol Online J"},{"key":"316_CR33","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1136\/annrheumdis-2017-212104","volume":"77","author":"JF Swart","year":"2018","unstructured":"Swart JF, van Dijkhuizen EHP, Wulffraat NM, de Roock S. Clinical juvenile arthritis disease activity score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis. Ann Rheum Dis. 2018;77:336\u201342.","journal-title":"Ann Rheum Dis"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-019-00316-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-019-00316-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-019-00316-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T20:14:50Z","timestamp":1721852090000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-019-00316-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,14]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["316"],"URL":"https:\/\/doi.org\/10.1007\/s12519-019-00316-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739330119.793582475","asserted-by":"object"}]},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,14]]},"assertion":[{"value":"20 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study has been approved by the Institutional Review Board of Chongqing Medical University and has been performed in accordance with the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}